| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.031 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |